Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1971 1
1972 1
1974 1
1977 1
1979 1
1982 2
1984 1
1987 2
1988 2
1989 4
1990 1
1991 2
1992 1
1993 1
1995 1
1996 2
1997 3
1998 1
1999 3
2000 4
2001 3
2002 1
2003 5
2004 2
2005 2
2006 8
2007 4
2008 14
2009 20
2010 14
2011 16
2012 15
2013 9
2014 20
2015 8
2016 7
2017 20
2018 13
2019 12
2020 16
2021 6
2022 14
2023 17
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

258 results

Results by year

Filters applied: . Clear all
Page 1
LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer.
Tavazoie MF, Pollack I, Tanqueco R, Ostendorf BN, Reis BS, Gonsalves FC, Kurth I, Andreu-Agullo C, Derbyshire ML, Posada J, Takeda S, Tafreshian KN, Rowinsky E, Szarek M, Waltzman RJ, Mcmillan EA, Zhao C, Mita M, Mita A, Chmielowski B, Postow MA, Ribas A, Mucida D, Tavazoie SF. Tavazoie MF, et al. Among authors: mita a. Cell. 2018 Feb 8;172(4):825-840.e18. doi: 10.1016/j.cell.2017.12.026. Epub 2018 Jan 11. Cell. 2018. PMID: 29336888 Free PMC article.
Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid Tumors.
Bahleda R, Italiano A, Hierro C, Mita A, Cervantes A, Chan N, Awad M, Calvo E, Moreno V, Govindan R, Spira A, Gonzalez M, Zhong B, Santiago-Walker A, Poggesi I, Parekh T, Xie H, Infante J, Tabernero J. Bahleda R, et al. Among authors: mita a. Clin Cancer Res. 2019 Aug 15;25(16):4888-4897. doi: 10.1158/1078-0432.CCR-18-3334. Epub 2019 May 14. Clin Cancer Res. 2019. PMID: 31088831 Clinical Trial.
A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors.
Bauer TM, Moore KN, Rader JS, Simpkins F, Mita AC, Beck JT, Hart L, Chu Q, Oza A, Tinker AV, Imedio ER, Kumar S, Mugundu G, Jenkins S, Chmielecki J, Jones S, Spigel D, Fu S. Bauer TM, et al. Among authors: mita ac. Target Oncol. 2023 Jul;18(4):517-530. doi: 10.1007/s11523-023-00965-7. Epub 2023 Jun 6. Target Oncol. 2023. PMID: 37278879 Free PMC article. Clinical Trial.
Palladium Complexes of N-Methylcorroles.
Pizzoli F, Mita A, Caroleo F, Nardis S, Calice U, Caporale M, Belviso S, Superchi S, Marconi A, Calvaresi M, Capolungo C, Prodi L, Smith KM, Fronczek FR, Paolesse R. Pizzoli F, et al. Among authors: mita a. Chemistry. 2023 Nov 16;29(64):e202302517. doi: 10.1002/chem.202302517. Epub 2023 Oct 20. Chemistry. 2023. PMID: 37675975
Maternal and Fetal Metabolites in Gestational Diabetes Mellitus: A Narrative Review.
Vladu IM, Clenciu D, Mitrea A, Amzolini A, Micu SE, Crisan AE, Efrem IC, Fortofoiu M, Fortofoiu MC, Mita A, Barau Alhija A, Glodeanu AD, Mota M. Vladu IM, et al. Among authors: mita a. Metabolites. 2022 Apr 22;12(5):383. doi: 10.3390/metabo12050383. Metabolites. 2022. PMID: 35629887 Free PMC article. Review.
Phase 1 study to determine the safety and dosing of autologous PBMCs modified to present HPV16 antigens (SQZ-PBMC-HPV) in HLA-A*02+ patients with HPV16+ solid tumors.
Jimeno A, Baranda J, Iams WT, Park JC, Mita M, Gordon MS, Taylor M, Dhani N, Leal AD, Neupane P, Eng C, Yeku O, Mita A, Moser JC, Butler M, Loughhead SM, Jennings J, Miselis NR, Ji RR, Nair N, Kornacker M, Zwirtes RF, Bernstein H, Sharei A. Jimeno A, et al. Among authors: mita a. Invest New Drugs. 2023 Apr;41(2):284-295. doi: 10.1007/s10637-023-01342-x. Epub 2023 Mar 3. Invest New Drugs. 2023. PMID: 36867316 Free PMC article. Clinical Trial.
Heat shock proteins: a potential anticancer target.
Sankhala KK, Mita MM, Mita AC, Takimoto CH. Sankhala KK, et al. Among authors: mita ac. Curr Drug Targets. 2011 Dec;12(14):2001-8. doi: 10.2174/138945011798829339. Curr Drug Targets. 2011. PMID: 21777196 Review.
258 results